Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,375
Closed -$1.27M 66
2021
Q4
$1.27M Sell
9,375
-2,875
-23% -$340K 0.53% 49
2021
Q3
$1.32M Sell
12,250
-7,075
-37% -$808K 0.57% 49
2021
Q2
$2.18M Sell
19,325
-915
-5% -$103K 1.09% 32
2021
Q1
$2.19M Sell
20,240
-3,260
-14% -$349K 1.23% 32
2020
Q4
$2.52M Buy
23,500
+2,000
+9% +$192K 1.48% 24
2020
Q3
$1.88M Sell
21,500
-26,125
-55% -$2.46M 1.42% 31
2020
Q2
$4.68M Sell
47,625
-7,625
-14% -$671K 3.83% 6
2020
Q1
$4.21M Buy
55,250
+51,250
+1,281% +$4.37M 3.91% 7
2019
Q4
$354K Sell
4,000
-3,000
-43% -$249K 0.2% 50
2019
Q3
$530K Buy
7,000
+750
+12% +$51.4K 0.26% 52
2019
Q2
$455K Buy
+6,250
New +$491K 0.26% 47
2018
Q3
Sell
-3,400
Closed -$315K 68
2018
Q2
$315K Sell
3,400
-100
-3% -$9.77K 0.13% 62
2018
Q1
$331K Sell
3,500
-400
-10% -$43.9K 0.14% 61
2017
Q4
$377K Buy
+3,900
New +$368K 0.11% 143

Other funds holding ABBV

Game Creek Capital's ABBV Position: Q1 2022 in Review

Game Creek Capital sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 9,375 shares — an estimated $1.27M sold.

Game Creek Capital first reported a position in ABBV in Q4 2017 and held it in 14 quarters. The position peaked at $4.68M in Q2 2020. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • Game Creek Capital reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
  • Game Creek Capital sold 9,375 AbbVie shares in Q1 2022, an estimated $1.27M.
  • Game Creek Capital first reported a position in AbbVie in Q4 2017 and held it in 14 quarters.
  • Game Creek Capital's AbbVie position peaked at $4.68M in Q2 2020.
  • 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Game Creek Capital's 13F filing for Q1 2022, filed 13 May 2022.